describes our experience in the use of GKS for patients whose TN was associated with VBE and compares pain outcomes in this subset of patients with TN with the outcomes of matched patients without VBE. This retrospective study was approved by the University of Pittsburgh Institutional Review Board.
Methods

Patient Population
Between April 1992 and May 2010, 919 GKS procedures were performed in 776 patients with medically refractory TN at the University of Pittsburgh Medical Center. Of these, 20 patients had evidence of VBE associated with ipsilateral TN on MR imaging or CT scanning studies. The following criteria were used to confirm VBE: a minimum of a 4.5-mm-diameter, tortuous vertebrobasilar arterial system associated with compression of the trigeminal nerve and/or brainstem in a patient with ipsilateral TN. All patients had longstanding pain resistant to medical management with agents such as carbamazepine, phenytoin, baclofen, or gabapentin alone or in combination.
The clinical demographic data are shown in Table 1 . There were 14 male and 6 female patients. The median patient age at GKS was 74 years (range 48-95 years), and the median symptom duration was 6 years (range 2-30 years). At GKS, the pain was predominantly present in the V2 and V3 distributions of trigeminal nerve (45%), followed by V2 (20%), V3 alone (15%), V1 plus V2 (10%), and all trigeminal distributions (10%). Eleven patients (55%) had undergone one or more surgical procedures prior to GKS. These procedures included MVD in 2 patients, PRGR in 8 patients, PRFL in 2 patients, PBM in 1 patient, microscopic trigeminal rhizotomy in 1 patient, and peripheral neurectomy in 1 patient. Fifteen patients (75%) had typical tic douloureux (Type I TN), and 5 (25%) described atypical components such as burning or persistent, lingering pain (Type II TN). Arterial hypertension was present in 15 patients (75%). No patient had tumor-or multiple sclerosis-related TN.
Radiosurgical Procedure
Various models of the Leksell Gamma Knife (U, B, C, 4C, and Perfexion; Elekta Instruments, Inc.) were used during this 18-year study. After induction of local anesthesia and application of the Leksell Model G stereotactic frame (Elekta Instruments), 18 patients underwent stereotactic MR imaging to identify the trigeminal nerve. We used CT scans in 2 patients who were ineligible for MR imaging. The MR imaging was performed using contrast-enhanced, short repetition time sequences and axial phase volume acquisitions of 512 × 216 matrices divided into 1-mm slices. When the trigeminal nerve was difficult to identify on images (usually because of previous surgery), additional axial long relaxation time MR imaging studies were obtained. Each patient's treatment plan was generated using the Leksell GammaPlan treatment planning system (Elekta AB).
A single 4-mm isocenter was used in 16 patients (80%), and two 4-mm isocenters were used in 4 patients (20%). A single isocenter was targeted at the cisternal segment of the trigeminal nerve. The isocenter was usually located so that the brainstem surface was irradiated at or below the 20% isodose line. When 2 isocenters were used to create an ovoid dose plan, a longer nerve segment extending more anteriorly was irradiated. The maximum target doses varied from 75 to 85 Gy (median 80 Gy). A team consisting of a neurosurgeon, a radiation oncologist, and a medical physicist was involved in all aspects of the procedure.
Follow-Up and Evaluation of Treatment Outcome
Clinical follow-up information was obtained either at the time of face-to-face assessment at our center (17 patients) or by direct telephone contact performed by one of the authors (3 patients). We evaluated the degree of pain relief, latency interval until pain relief, need for further surgical procedures, continued requirement for medication, development of new symptoms or signs, and need for and response to additional surgical procedures. The median follow-up period was 29 months (range 8-123 months) after the radiosurgical procedure. The pain outcome was evaluated using the BNI pain intensity scoring criteria, as follows: Grade I: no pain, no medication; Grade II: occasional pain, not requiring medication; Grade IIIa: no pain, but continued medication; Grade IIIb: pain present, but adequately controlled with medication; Grade IV: pain present, but not adequately controlled with medication; and Grade V: severe pain despite medication. 29 We considered BNI Grades I-IIIb as designating successful treatment (adequate pain relief), representing pain improvement without requirement for further surgical management. Treatment failure was defined as BNI Grades IV and V. We also sought information about the patient's corneal sensation and whether there was any difficulty with mastication.
Matching to Patients Without VBE
Of the 776 patients who underwent GKS for idiopathic TN in our center over the last 18 years, 756 had no evidence of VBE and were eligible to serve as potential case control matches. Individuals with VBE (20 patients; case cohort) were matched to patients with identical sex, same nature of pain (typical vs atypical), history of failed operative procedures, similar age (difference between groups, 5 years or less), and similar follow-up duration (difference between groups, 6 months or less) who did not demonstrate VBE (80 patients; control cohort). The rates of initial pain relief, recurrence of pain, maintenance of pain relief, and complications after GKS were assessed in both patient cohorts.
Statistical Analysis
The rates of pain improvement were calculated, and the maintenance rate of pain improvement for patients showing an initial response was evaluated using the Kaplan-Meier method. We examined the statistical relationship between outcomes and various factors including age, sex, duration of symptoms, history of failed surgical procedures, pain distribution, presence of atypical pain, new development or worsening of preexisting sensory abnormality, maximum target dose, and displacement of brainstem or trigeminal nerve by using the chi-square test, Fisher exact test, and Mann-Whitney U-test. The outcomes of patients with VBE were compared with non-VBE controls by using a log-rank test, chi-square test, Fisher exact test, and Mann-Whitney U-test. All statistical analysis was performed using SPSS software (version 17.0; SPSS, Inc.), and p < 0.05 was considered statistically significant.
Results
The outcomes of individual patients are outlined in Fig. 1 . The responses of the patients to GKS are shown in Table 2 .
Pattern of Neurovascular Compression by VBE
All 20 patients demonstrated vascular compression of the ipsilateral trigeminal nerve, the brainstem itself, or both. The vessels involved were the BA in 13 patients and the VA in 7 patients. Twelve patients (60%) demonstrated distortion of the trigeminal nerve in a cephalad or lateral direction. Deformation of the brainstem was documented in 10 patients (50%) (Fig. 2 upper) . In 16 patients (80%), intraoperative imaging clearly revealed the entire cisternal nerve segment. For these patients, the target was 3-8 mm anterior to the junction of the trigeminal nerve and the pons. In 4 patients (20%), we could identify only the distal cisternal component of the trigeminal nerve as it entered into the Meckel cave. The target of these patients was selected as 2-3 mm posterior to the entry of the nerve into the Meckel cave (Fig. 2 lower) .
Initial Pain Response to GKS
Fifteen patients (75%) achieved adequate initial pain control (BNI Grades I-IIIb) after GKS; 6 patients (30%) achieved complete initial pain relief (BNI Grade I). Five patients (25%) had insufficient pain relief after the procedure (BNI Grades IV and V). The median interval until pain improvement was 5 weeks after radiosurgery (range 1 day-6 months). Twelve patients (60%) experienced pain improvement within 3 months. 
Maintenance of Pain Relief After GKS
Although 15 patients had adequate initial pain control, 12 patients had pain recurrence (BNI Grades IV and V). The median time to recurrence was 12 months (range 3-43 months). The duration of pain relief after the initial response was evaluated using the Kaplan-Meier method. The probability of maintaining pain relief (BNI Grades I-IIIb) was 53% at 1 year, 38% at 2 years, 20% at 3 years, 
Sensory Dysfunction After GKS
No patient sustained an early perioperative complication after GKS. During the follow-up interval, 2 patients (10%) developed new or increased trigeminal sensory dysfunction at 2 and 4 months after GKS, respectively. Both of these patients achieved initial pain relief (BNI Grades I-IIIb) after GKS, but 1 patient had delayed pain recurrence. The sensory loss was transient in 1 patient and persisted in 1 additional patient. Neither patient developed annoying paresthesias or dysesthesias. No patient developed corneal sensory loss, a trigeminal motor deficit, or other cranial nerve deficits after GKS.
Comparisons of Outcomes to Patients With Non-VBE TN
The demographic and clinical data for the patients with VBE and those without this disorder are summarized in Table 3 . There were no significant differences in baseline characteristics between the groups.
Patients with VBE were less likely to achieve ade- quate pain relief (BNI Grades I-IIIb) compared with controls (75% vs 93%; p = 0.025). The latency to pain relief was longer in patients with VBE (5 vs 2 weeks), but it did not reach statistical significance (p = 0.091). The probability of maintaining pain relief (BNI Grades I-IIIb) in patients without VBE was 79%, 69%, 57%, and 42% at 1, 2, 3, and 5 years, respectively, which was superior to that in patients with VBE (p = 0.006; Fig. 3 ).
There were no significant differences between patients with and without VBE in the rates of initial complete pain relief (BNI Grade I; p = 0.600), time to pain recurrence (p = 0.250), and postoperative sensory changes (p = 0.730).
Additional Pain Management After GKS
Five patients had insufficient initial pain relief (BNI Grades IV and V) and 12 developed recurrent pain (BNI Grades IV and V) despite initial relief. Fourteen of these 17 patients underwent an additional surgical procedure at a median of 14 months (range 5-50 months) after initial GKS. Eight (40%) had a repeat GKS, 4 (20%) underwent PRGR, 3 (15%) had MVD, and 1 (5%) had PRFL (2 of the patients who underwent additional treatments had both repeat GKS and PRGR). Three patients had not undergone any further surgery by the time of final follow-up of this report. One patient who underwent a second GKS had BNI Grade I; 2 had Grade II; 1 had Grade IIIa; 2 had Grade IIIb; and 2 had Grade V after a second GKS. The 2 patients who did not achieve pain control after repeat GKS were then treated with PRGR and had adequate pain relief following the last procedure. One patient who underwent PRGR had BNI Grade IIIa at last follow-up, and the other had temporary improvement, but the pain later recurred (BNI Grade IV). One patient who had PRFL did not achieve pain relief (BNI Grade V). All 3 patients who underwent MVD had good outcomes at last follow-up (BNI Grade I in 2 patients and Grade II in 1 patient).
At the last assessment, 15 patients (75%) had satisfactory pain control (BNI Grades I-IIIb). The median follow-up duration in this subgroup of patients was 13 months (range 3-77 months) between their last surgical procedure and the latest follow-up evaluation. Three patients (15%) achieved BNI Grade I; 3 (15%) had Grade II; 6 (30%) had Grade IIIa; and 3 (15%) had Grade IIIb. Five patients (25%) continued to have uncontrolled or severe pain (BNI Grades IV and V) (Fig. 1) .
Discussion
Trigeminal neuralgia is estimated to have an annual incidence of 27 per 100,000. The pain is characterized by sharp, intermittent, and often severe attacks of pain affecting the dermatomal distribution of the trigeminal nerve. 3 The source of the pain for many patients with TN is re- lated to vascular compression of the trigeminal nerve.
14 This compression leads to local nerve demyelination and axonopathy, leading to ephaptic transmission between the damaged heavily myelinated fibers and smaller unmyelinated pain fibers. For such patients, nerve firing after minor stimulation mediated via myelinated fibers (for example, light touch) induces a burst of spontaneous firing, perceived as intense pain, which lasts for seconds or minutes. 5, 6 Trigeminal neuralgia is related to vascular cross-compression produced by the SCA (75%-88%) and AICA (6%-25%). Less commonly, regional draining veins of the pons or cerebellum (6%-13%) may cause TN. 2, 19, 30 Other rare causes include primary demyelinating disorders, 4, 36 infarcts of the brainstem, 13, 27 tumors, and other masses of the posterior fossa.
1,17
Vertebrobasilar Ectasia as a Cause of TN
Vertebrobasilar ectasia refers to pathological enlargement and distortion of the vertebrobasilar arterial system. 35 This disorder may be related to a structural arterial wall defect of the internal elastic lamina. In patients with normal vessels, the mean diameters of the VA and BA are 2.6 and 2.7 mm, respectively. If the artery has a diameter > 4.5 mm, VBE can be considered present. 31 The disorder may be asymptomatic, or it may be associated with clinical manifestations such as posterior circulation stroke or transient ischemic attacks, intracranial bleeding, compression of brainstem, or obstructive hydrocephalus. 21 Sometimes, an ectatic vertebrobasilar vessel can be the sole cause of significant trigeminal nerve root compression and resultant TN. Linskey et al., 22 in describing a series of 1404 patients treated with MVD, reported the prevalence of an enlarged VBA as the offending vessel in TN as 2%. They noted that the patients with vertebrobasilar compressions as the cause for their TN differ from the other patients with TN (caused by small vessels) in that they are older (62 vs 55 years), are more often male (68% vs 39%), are more likely to suffer from hypertension (65% vs 18%), and tend to be affected on the left side (65% vs 39%). Similar results were reported in a recently published surgical series in which the mean age of the patients was 65 years, 60% were male, 60% had hypertension, and 60% were affected on the left side. 8 In the current series of 20 cases of TN associated with VBE, the median age of the patients was 74 years, 70% were male, 75% were hypertensive, and 60% were affected on the left side. As noted in the present series, GKS is more often advocated in patients with advanced age or medical comorbidities. The association of TN caused by VBE with increasing age, male sex, and hypertension may be due to a more general association of these 3 factors with atherosclerosis. 22 It appears that the hemodynamic effect of long-term high blood flow through the atherosclerotic vessels produces tortuosity of the artery. 18, 32 The suspected stronger transmission of pulse pressure to the left VA from the subclavian artery (which has its origin from the aortic arch rather than the brachiocephalic trunk) may explain the more common left-sided involvement. 10, 22 In addition, it is possible that left-sided vertebrobasilar compression might also contribute to hypertension from concomitant medullary compression. 15, 16, 26 Use of MVD for TN Associated With VBE Microvascular decompression has become widely accepted as a logical and valuable method for management of TN. A large surgical series reported by Barker et al. 2 noted that MVD provided immediate pain relief that was complete in 82% and partial in 16%. At follow-up assessment 10 years after the procedure, 64% had excellent results and 4% had partial relief. However, surgical treatment of TN caused by VBE presents several potential surgical challenges. Because the tortuous vertebrobasilar vessels are often firm and difficult to decompress, insertion of a Teflon barrier between the artery and the nerve is not easily performed. Despite these technical issues, there are several reports showing the success of MVD in patients with VBE. Miyazaki et al. 25 noted that 96% of patients had complete pain relief in 45 consecutive cases with a mean follow-up period of 19 months. Similarly, Linskey et al. 22 reported 31 consecutive patients with VBE-related TN, all of whom had complete pain resolution immediately postoperatively. The pain-free rate was 96% at 1 year, 92% at 3 years, and 86% at 10 years. Recently, El-Ghandour 8 described 10 patients who underwent MVD for TN caused by VBE. Complete resolution of TN was observed in 80% of patients, and none of them had a recurrence in the mean follow-up period of 7.8 years. Despite excellent pain management outcomes, postoperative cranial nerve deficits are much more likely after MVD for VBE-associated TN. Miyazaki et al. described new postoperative trigeminal sensory dysfunction in 29%, diplopia in 24%, facial paresis in 7%, and hearing loss in 4%. Permanent neurological deficits were encountered in 11%. Linskey et al. described the development of sensory disturbance in 42%, transient diplopia in 23%, and hearing impairment in 13%. El-Ghandour reported transient diplopia in 10%, caused by trochlear nerve paresis, and facial weakness developed in 10%. Such complications reflect the difficulty involved in surgical decompression of a tortuous vertebrobasilar system near critical cranial nerve structures.
The ideal goal of management for TN is elimination or relief of facial pain. To achieve this, there is a balance between surgical risk, maintenance of normal cranial nerve function, and the expectation of pain control. For patients with medically refractory TN associated with VBE, we consider MVD as a first-line surgical treatment option if the individual has satisfactory medical risk factors. The poorer long-term pain control we observed after GKS provides more reason for younger and healthier patients with medically refractory TN associated with VBE to accept higher complication risks in choosing MVD for first-line surgical management than similar patients with TN who do not have VBE. Unfortunately, many patients with VBE are poor candidates for a major posterior fossa surgical procedure because of advanced age or the presence of other medical comorbidities. In such patients, other less invasive options are necessary.
Gamma Knife Surgery for TN With VBE
The benefits of GKS for idiopathic TN have been well established. Between 78% and 96% of patients have initial pain relief, and 41%-71% maintain pain relief at 3 years after the procedure. 7, 9, 12, 20, 28, 33, 34 However, the role of GKS for TN associated with VBE has not been defined yet, and only scattered cases have been reported. Lorenzoni et al. 24 reported the influence of the anatomy of neurovascular compression on pain outcome in 89 consecutive patients with TN treated using GKS, including 4 patients with compression caused by VBE (2 had BA and 2 had VA compression). These investigators noted that treatment failed in all 4 patients and suggested that the outcomes of TN related to large-vessel neurovascular compression were worse.
In the present study, we found that 75% of patients with VBE achieved initially adequate pain control (BNI Grades I-IIIb). However, only 30% achieved BNI Grade I. The majority of patients (60%) had pain relief within 3 months (median 5 weeks, range 1 day-6 months). During the median follow-up of 29 months, 60% experienced pain recurrence, and 10% developed new or increased trigeminal sensory loss between 2 and 4 months after GKS. Fifty-three percent achieved initial pain relief and maintained pain control (BNI Grades I-IIIb) at 1 year, 20% maintained it at 3 years, and 10% at 5 years. When we compared this outcome with those of matched patients without VBE, we found that patients with VBE were less likely to achieve initial adequate pain relief (p = 0.025) and were less likely to maintain pain relief (p = 0.006).
Percutanous Procedures and Multimodality Treatment for TN Associated With VBE
Percutanous procedures such as glycerol rhizotomy, radiofrequency thermocoagulation, and balloon microcompression are alternative surgical procedures for the management of TN. In a systematic review of the literature concerning ablative neurosurgical procedures (which include both percutanous procedures and stereotactic radiosurgery), Lopez et al. 23 noted that radiofrequency lesioning seems to provide better rates of complete pain control, but it was associated with a greater number of complications. Henson et al. 11 compared the results of glycerol rhizotomy to those after GKS. They found that glycerol rhizotomy was associated with greater perioperative morbidity and a higher failure rate than GKS, although it provided faster pain relief. In patients with severe medically or surgically refractory TN in certain cases (as seen in this series) and in whom there are significant medical risk factors associated with posterior fossa surgery, we prefer GKS. This procedure has the least risk of major sensory loss. We advocate glycerol rhizotomy for patients who have severe, medically refractory pain that interferes with eating and drinking. Such patients require a procedure with a higher likelihood of early pain relief.
In the current study, 15 patients (75%) achieved adequate pain relief (BNI Grades I-IIIb) after 1 or more procedures. Of them, most (12 of 15; 80%) required more than 1 surgical procedure to attain satisfactory pain control, and 60% continued to receive medical management.
Conclusions
In this study, we found that the pain control rates of GKS in patients with TN associated with VBE are inferior to those of patients without VBE. Despite initial pain improvement in most patients, additional medical or surgical pain management was required in the majority within 3 years after GKS. Although vascular decompression provides the best pain outcomes for eligible patients, the low risk of postoperative complications provides a continued, important rationale for GKS in this rare condition.
